Occudo Quantitative Strategies LP Gritstone Bio, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$2.46 - $4.75 $252,359 - $487,278
-102,585 Reduced 71.67%
40,552 $104,000
Q2 2022

Aug 15, 2022
BUY
$1.77 - $4.34 $253,352 - $621,214
143,137 New
143,137 $346,000
Q1 2021

May 14, 2021
SELL
$4.07 - $27.11 $50,529 - $336,570
-12,415 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$2.57 - $4.22 $31,906 - $52,391
12,415 New
12,415 $49,000

Others Institutions Holding GRTS

# of Institutions
62
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email